Vifor CEO Abbas Hussain
Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing
Australian firm CSL paid a steep price earlier this week for Vifor Pharma and its pipeline of iron and kidney drugs. Looking to ensure it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
